Insulet Profit Margin 2010-2025 | PODD

Current and historical gross margin, operating margin and net profit margin for Insulet (PODD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Insulet net profit margin as of March 31, 2025 is 18.29%.
Insulet Annual Profit Margins
Insulet Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.991B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $223.656B 26.24
Stryker (SYK) United States $152.832B 31.96
EssilorLuxottica (ESLOY) France $137.378B 0.00
Medtronic (MDT) Ireland $117.532B 16.66
Lonza Group Ag (LZAGY) Switzerland $49.462B 0.00
Haleon (HLN) United Kingdom $43.306B 24.72
ResMed (RMD) United States $40.680B 30.56
Agilent Technologies (A) United States $33.534B 21.86
GE HealthCare Technologies (GEHC) United States $32.803B 15.37
Koninklijke Philips (PHG) Netherlands $25.816B 17.08
Terumo (TRUMY) Japan $25.125B 32.63
Zimmer Biomet Holdings (ZBH) United States $18.463B 11.86
Baxter (BAX) United States $14.395B 10.75
Smith & Nephew SNATS (SNN) United Kingdom $13.547B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.805B 23.68
Lantheus Holdings (LNTH) United States $4.970B 12.54
Perrigo (PRGO) Ireland $3.781B 9.58
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.644B 16.60
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.383B 28.11
ICU Medical (ICUI) United States $3.088B 22.77
LeMaitre Vascular (LMAT) United States $1.852B 41.40
AtriCure (ATRC) United States $1.739B 0.00
QuidelOrtho (QDEL) United States $1.643B 11.30
Acuren (TIC) United States $1.391B 0.00
Green Thumb Industries (GTBIF) United States $1.271B 28.60
AdaptHealth (AHCO) United States $1.232B 12.51
Phibro Animal Health (PAHC) United States $1.132B 14.47
Neogen (NEOG) United States $1.019B 16.19
Curaleaf Holdings (CURLF) Canada $0.939B 0.00
InMode (INMD) Israel $0.879B 8.13
Kestra Medical Technologies (KMTS) United States $0.856B 0.00
Valneva SE (VALN) France $0.651B 0.00
Tilray Brands (TLRY) Canada $0.616B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.614B 0.00
Evolus (EOLS) United States $0.578B 0.00
Owens & Minor (OMI) United States $0.549B 4.56
CeriBell (CBLL) United States $0.539B 0.00
Surmodics (SRDX) United States $0.535B 0.00
ZimVie (ZIMV) United States $0.526B 20.52
SNDL (SNDL) Canada $0.378B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.342B 0.00
Cresco Labs (CRLBF) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.308B 0.00
VAREX IMAGING (VREX) United States $0.307B 11.29
Quanterix (QTRX) United States $0.304B 0.00
Aurora Cannabis (ACB) Canada $0.254B 75.33
Cerus (CERS) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.244B 20.60
OraSure Technologies (OSUR) United States $0.239B 0.00
Omeros (OMER) United States $0.238B 0.00
Sanara MedTech (SMTI) United States $0.223B 0.00
Canopy Growth (CGC) Canada $0.215B 0.00
Verano Holdings (VRNOF) United States $0.215B 0.00
Exagen (XGN) United States $0.190B 0.00
Organigram Global (OGI) Canada $0.184B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.07
Vireo Growth (VREOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.172B 0.00
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
TerrAscend (TSNDF) Canada $0.131B 0.00
FitLife Brands (FTLF) United States $0.117B 14.37
Jushi Holdings (JUSHF) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.62
MacroGenics (MGNX) United States $0.097B 0.00
Quipt Home Medical (QIPT) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Veru (VERU) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.072B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
United-Guardian (UG) United States $0.036B 12.51
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00